These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 33258081)
21. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy. Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838 [TBL] [Abstract][Full Text] [Related]
22. ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure. Madonna R; Van Laake LW; Botker HE; Davidson SM; De Caterina R; Engel FB; Eschenhagen T; Fernandez-Aviles F; Hausenloy DJ; Hulot JS; Lecour S; Leor J; Menasché P; Pesce M; Perrino C; Prunier F; Van Linthout S; Ytrehus K; Zimmermann WH; Ferdinandy P; Sluijter JPG Cardiovasc Res; 2019 Mar; 115(3):488-500. PubMed ID: 30657875 [TBL] [Abstract][Full Text] [Related]
23. Cell therapy trials for heart regeneration - lessons learned and future directions. Menasché P Nat Rev Cardiol; 2018 Nov; 15(11):659-671. PubMed ID: 29743563 [TBL] [Abstract][Full Text] [Related]
24. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice. Fan C; Tang Y; Zhao M; Lou X; Pretorius D; Menasche P; Zhu W; Zhang J J Mol Cell Cardiol; 2020 Apr; 141():1-10. PubMed ID: 32169551 [TBL] [Abstract][Full Text] [Related]
25. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821 [TBL] [Abstract][Full Text] [Related]
27. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction. Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499 [TBL] [Abstract][Full Text] [Related]
28. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise. Duelen R; Sampaolesi M EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191 [TBL] [Abstract][Full Text] [Related]
29. Transplantation of Epigenetically Modified Adult Cardiac c-Kit+ Cells Retards Remodeling and Improves Cardiac Function in Ischemic Heart Failure Model. Zakharova L; Nural-Guvener H; Feehery L; Popovic-Sljukic S; Gaballa MA Stem Cells Transl Med; 2015 Sep; 4(9):1086-96. PubMed ID: 26240433 [TBL] [Abstract][Full Text] [Related]
30. Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges. Choi SH; Jung SY; Kwon SM; Baek SH Circ J; 2012; 76(6):1307-12. PubMed ID: 22739079 [TBL] [Abstract][Full Text] [Related]
31. Regenerative Therapy for Cardiomyopathies. Wang Z; Su X; Ashraf M; Kim IM; Weintraub NL; Jiang M; Tang Y J Cardiovasc Transl Res; 2018 Oct; 11(5):357-365. PubMed ID: 29744805 [TBL] [Abstract][Full Text] [Related]
32. Cardiac regeneration in 2017: Novel paradigms in the fight against heart failure. Fernández-Avilés F Nat Rev Cardiol; 2018 Jan; 15(2):73-74. PubMed ID: 29336435 [No Abstract] [Full Text] [Related]
33. Advances in cell-based therapy for structural heart disease. Mazhari R; Hare JM Prog Cardiovasc Dis; 2007; 49(6):387-95. PubMed ID: 17498519 [TBL] [Abstract][Full Text] [Related]
34. New era of heart failure therapy in pediatrics: Cardiac stem cell therapy on the start line. Sano S; Ishigami S; Sano T J Thorac Cardiovasc Surg; 2019 Sep; 158(3):845-849. PubMed ID: 31248633 [No Abstract] [Full Text] [Related]
35. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure. Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990 [TBL] [Abstract][Full Text] [Related]
36. Future prospects for regenerated heart using induced pluripotent stem cells. Fujita J; Fukuda K J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283 [TBL] [Abstract][Full Text] [Related]
38. Cardiac regenerative therapy: Many paths to repair. Gude NA; Sussman MA Trends Cardiovasc Med; 2020 Aug; 30(6):338-343. PubMed ID: 31515053 [TBL] [Abstract][Full Text] [Related]
39. Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy. Ma R; Liang J; Huang W; Guo L; Cai W; Wang L; Paul C; Yang HT; Kim HW; Wang Y Antioxid Redox Signal; 2018 Feb; 28(5):371-384. PubMed ID: 27903111 [TBL] [Abstract][Full Text] [Related]
40. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction. Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]